Aniracetam binding in the GluR2 ligand-binding core
Biochemical assay · Purified rat GluR2 flop-derived S1S2J ligand-binding core with fluorowillardiine. [1]
The cocrystal places aniracetam in a single site at the dimer interface near the clamshell hinge. Two modeled orientations each have occupancy 0.5; these represent one bound molecule per interface, rather than two simultaneously bound molecules.
| Endpoint | Reported result | Reference |
|---|---|---|
| Ani/fluorowillardiine cocrystal diffraction resolution | Resolution 1.65 Å | [1] |
| Location of aniracetam in the receptor complex | Structural localization Dimer interface, adjacent to the clamshell hinge | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 10 mM aniracetam; 5 mM fluorowillardiine added before crystallization
- Method
- Cocrystallization of purified ligand-binding core; diffraction and structural refinement.
- Co-treatment
- Fluorowillardiine is the agonist in the aniracetam complex.
- Reported limits
- These concentrations are crystallization inputs, not affinity or potency values. Crystallization time is not specified in the acquired methods.
Methods and source locations
Compound reported in the paper: Aniracetam; Compound label in the paper: Ani
Evidence for the named parent compound in the specified receptor systems; no supplier-lot validation.
Materials and Methods: Materials, Crystallization and measurement of diffraction data, Structure determination; Results: Structures of Ani/FW and CX/Quis complexes; Tables 1–2; Figures 1B, 2A, 3A–B
Ani/fluorowillardiine cocrystal diffraction resolution: X-ray crystallography — Results: Structures of Ani/FW and CX/Quis complexes; Tables 1–2
Location of aniracetam in the receptor complex: Electron density and structural model — Results: Structures of Ani/FW and CX/Quis complexes; Figures 2A and 3A–B